Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Interstim Implant For Sns

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07563764Not ApplicableRecruiting

Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome

NCT05064384Completed

Axonics SacRal NeuromodulaTIon System RegisTRY Study

NCT00943904Not ApplicableCompleted

Comparison of Motor and Sensory Response With Interstim Stimulation

Showing all 3 trials

Research Network

Common Treatments

  • Interstim Implant For Sns1
  • Lowenergy Extracorporeal Shock Wave Therapy Lieswt1
  • Sham Shock Wave Therapy1

Active Sponsors

  • Axonics, Inc.1
  • University of California, Irvine1
  • KMUHIRB-F(I)-202300511

Top Investigators

Related Conditions

  • Bladder1
  • Fecal Incontinence1
  • Lower Urinary Track Symptoms1
  • Bladder Overactive1
  • Metabolic Syndrome1

Activity Timeline